~~<i id='39F696811C'><strike id='39F696811C'><tt id='39F696811C'><pre id='39F696811C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：hotspot 2025-08-24 04:06:43 - browse：48

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： FDA advisers back CAR

hotspot

focus

hotspot

entertainment

VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Readout Newsletter: CAR

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

New England Journal of Medicine addresses racist history, slavery

Medicare coverage of Wegovy, once blocked, now looks possible

Risky weight loss products often used by teens globally, per study

hotspot

hotspot

hotspot

Affirmative action in medical school literally saved lives

Designating disabled people as health disparity population is crucial

Medical leaders decry Supreme Court decision on affirmative action

Pushing for an NIH office for post

Continuity nursing helped my family in our darkest PICU moments

UCLA team creates talking throat patch for voice disorders

United colonoscopy coverage change 'may cost lives,' doctors say

The SUPPORT Act is critical to fighting the opioid crisis

Apple is now the first public company to be valued at $3 trillion

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

focus

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Generative AI mines health records to identify patients’ social needs

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

The nurse manager staffing crisis is hurting patients

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

focus

focus

hotspot

entertainment